T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment
View ORCID ProfileAlfie R. Wearn, View ORCID ProfileVolkan Nurdal, Esther Saunders-Jennings, Michael J. Knight, View ORCID ProfileChristopher R. Madan, View ORCID ProfileSean-James Fallon, View ORCID ProfileHanna K. Isotalus, View ORCID ProfileRisto A. Kauppinen, View ORCID ProfileElizabeth J. Coulthard
doi: https://doi.org/10.1101/2020.11.03.20225177
Alfie R. Wearn
aBristol Medical School, University of Bristol, Bristol, UK
Volkan Nurdal
aBristol Medical School, University of Bristol, Bristol, UK
Esther Saunders-Jennings
aBristol Medical School, University of Bristol, Bristol, UK
Michael J. Knight
bSchool of Psychological Science, University of Bristol, Bristol, UK
Christopher R. Madan
dSchool of Psychology, University of Nottingham, Nottingham, UK
Sean-James Fallon
eNational Institute for Health Research Bristol Biomedical Research Centre, University Hospitals Bristol NHS Foundation Trust and University of Bristol, Bristol, UK
Hanna K. Isotalus
aBristol Medical School, University of Bristol, Bristol, UK
Risto A. Kauppinen
fFaculty of Engineering, University of Bristol, Bristol, UK
Elizabeth J. Coulthard
aBristol Medical School, University of Bristol, Bristol, UK
cClinical Neurosciences, North Bristol NHS Trust, Bristol, UK
Data Availability
The datasets used during the current study are available from the corresponding author on reasonable request.
Posted November 04, 2020.
T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment
Alfie R. Wearn, Volkan Nurdal, Esther Saunders-Jennings, Michael J. Knight, Christopher R. Madan, Sean-James Fallon, Hanna K. Isotalus, Risto A. Kauppinen, Elizabeth J. Coulthard
medRxiv 2020.11.03.20225177; doi: https://doi.org/10.1101/2020.11.03.20225177
T2 heterogeneity as an in vivo marker of microstructural integrity in medial temporal lobe subfields in ageing and mild cognitive impairment
Alfie R. Wearn, Volkan Nurdal, Esther Saunders-Jennings, Michael J. Knight, Christopher R. Madan, Sean-James Fallon, Hanna K. Isotalus, Risto A. Kauppinen, Elizabeth J. Coulthard
medRxiv 2020.11.03.20225177; doi: https://doi.org/10.1101/2020.11.03.20225177
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2942)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12743)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4583)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2916)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4351)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6937)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (488)
- Toxicology (60)
- Transplantation (212)
- Urology (180)